التفاصيل البيبلوغرافية
| العنوان: |
Computer-Aided Design, Synthesis, and Antiviral Evaluation of Novel Acrylamides as Potential Inhibitors of E3-E2-E1 Glycoproteins Complex from Chikungunya Virus. |
| المؤلفون: |
Passos, Gabriel Felipe Silva, Gomes, Matheus Gabriel Moura, Aquino, Thiago Mendonça de, Araújo-Júnior, João Xavier de, Souza, Stephannie Janaina Maia de, Cavalcante, João Pedro Monteiro, Santos, Elane Conceição dos, Bassi, Ênio José, Silva-Júnior, Edeildo Ferreira da |
| المصدر: |
Pharmaceuticals (14248247); Jul2020, Vol. 13 Issue 7, p141, 1p |
| مصطلحات موضوعية: |
CHIKUNGUNYA virus, COMPUTER-aided design, ACRYLAMIDE, GLYCOPROTEINS, COMMUNICABLE diseases, FLOW cytometry, CELL survival, ALPHAVIRUS diseases |
| مستخلص: |
Chikungunya virus (CHIKV) causes an infectious disease characterized by inflammation and pain of the musculoskeletal tissues accompanied by swelling in the joints and cartilage damage. Currently, there are no licensed vaccines or chemotherapeutic agents to prevent or treat CHIKV infections. In this context, our research aimed to explore the potential in vitro anti-CHIKV activity of acrylamide derivatives. In silico methods were applied to 132 Michael's acceptors toward the six most important biological targets from CHIKV. Subsequently, the ten most promising acrylamides were selected and synthesized. From the cytotoxicity MTT assay, we verified that LQM330, 334, and 336 demonstrate high cell viability at 40 µM. Moreover, these derivatives exhibited anti-CHIKV activities, highlighting the compound LQM334 which exhibited an inhibition value of 81%. Thus, docking simulations were performed to suggest a potential CHIKV-target for LQM334. It was observed that the LQM334 has a high affinity towards the E3-E2-E1 glycoproteins complex. Moreover, LQM334 reduced the percentage of CHIKV-positive cells from 74.07 to 0.88%, 48h post-treatment on intracellular flow cytometry staining. In conclusion, all virtual simulations corroborated with experimental results, and LQM334 could be used as a promising anti-CHIKV scaffold for designing new drugs in the future. [ABSTRACT FROM AUTHOR] |
|
Copyright of Pharmaceuticals (14248247) is the property of MDPI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder